A consensus document on the diagnosis and management of thrombotic microangiopathy (TMA) in Australia and New Zealand has highlighted the importance of treating patients empirically while waiting for ADAMTS13 test results. Co-author Dr Tom Barbour told the limbic plasma exchange should be implemented early, especially in adults, given the potential for rapid progression to end-state ...
“Siloed in our specialties – consensus statement aims to overcome treatment gaps in thrombotic microangiopathy
By Mardi Chapman
15 Feb 2018